Article metrics

Original research
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial

 

Online download statistics by month:

Online download statistics by month: July 2020 to April 2021

AbstractFullPdf
Jul 202011821182734
Aug 2020557552334
Sep 2020514514343
Oct 2020470470387
Nov 2020500498225
Dec 2020378378173
Jan 2021359359192
Feb 2021424424192
Mar 2021598598233
Apr 2021510510185
Total549254852998